Insider · CIK 0001451495
Sean F. Moran
Files at CRBP (Corbus Pharmaceuticals Holdings, Inc.). First filing Feb 18, 2025, latest Aug 10, 2026.
In brief
Sean F. Moran files SEC Form 4 as CFO at CRBP (Corbus Pharmaceuticals Holdings, Inc.). Since Feb 18, 2025, Sean F. Moran has reported 0 open-market buys worth $0 and 4 open-market sells worth $403k, the latest filed on Aug 10, 2026.
A track record needs three past buys with six months of prices behind them; Sean F. Moran has 0, so none is measured yet.
The newest scored trade: sold $121k of CRBP on Aug 7, 2026, filed Aug 10, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $378k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRBP: Corbus Pharmaceuticals Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Corbus Pharmaceuticals Holdings, Inc. | $121k 12,000 shares | -12% | +38% from low-47% from high | |
| 23Weak | Corbus Pharmaceuticals Holdings, Inc. | $37k 4,701 shares | -5% | +54% from low-61% from high | |
| 19Weak | Corbus Pharmaceuticals Holdings, Inc. | $221k 12,981 shares | -15% | +243% from low-13% from high | |
| 10Weak | Corbus Pharmaceuticals Holdings, Inc. | $24k 2,792 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | 12,981 0.11% of outstanding | $221k | Oct 24, 2025 | none |
| Feb 14, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | 2,792 0.02% of outstanding | $26k | Feb 14, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -12,000 | $10.08 | $121k | 84,694 | Aug 10, 2026 |
| Feb 13, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -4,701 | $7.78 | $37k | 96,694 | Feb 18, 2026 |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share | +28,082 | $0.00 | $0 | 101,395 | Jan 16, 2026 |
| Jan 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock options (right to buy)derivative | +84,247 | $0.00 | $0 | 84,247 | Jan 16, 2026 |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Common Stock, par value $0.0001 per share10b5-1 | +12,981 | $4.26 | $55k | 86,294 | Oct 27, 2025 |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -12,981 | $17.02 | $221k | 73,313 | Oct 27, 2025 |
| Oct 24, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Stock options (right to buy)derivative10b5-1 | -12,981 | $0.00 | $0 | 10,386 | Oct 27, 2025 |
| Feb 14, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -2,792 | $8.76 | $24k | 73,313 | Feb 18, 2025 |
| Jan 31, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share | +27,500 | $0.00 | $0 | 76,105 | Feb 4, 2025 |
| Jan 31, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock options (right to buy)derivative | +92,500 | $0.00 | $0 | 92,500 | Feb 4, 2025 |
Questions about Sean F. Moran
Answered from the filings on this page, as of the latest one.
Is Sean F. Moran buying or selling?
In the last 12 months Sean F. Moran reported 0 open-market buys worth $0 and 3 open-market sells worth $378k on SEC Form 4; the latest was sold $121k of CRBP on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Sean F. Moran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sean F. Moran has 0.
Where does Sean F. Moran file Form 4?
Sean F. Moran has filed Form 4 at CRBP (Corbus Pharmaceuticals Holdings, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.